(2026). Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Plasma Cell-free DNA Measured Prior to Renal Replacement Therapy Initiation Is Not Associated with Incident Adverse Outcomes, Hospitalizations or Malignancies in Chronic Kidney Disease Stage 4–5 Patients."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Plasma Cell-free DNA Measured Prior to Renal Replacement Therapy Initiation Is Not Associated with Incident Adverse Outcomes, Hospitalizations or Malignancies in Chronic Kidney Disease Stage 4–5 Patients."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.